Investing Profile

Hakan Goker

InvestorVC

Managing Director at M Ventures (Merck)

m-ventures.com/enAmsterdam, Netherlands

Your Intro Paths to Hakan Goker

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Hakan Goker on

Current Investing Position

M Ventures (Merck) Managing Director

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

€600M

Hakan Goker is on these Sector & Stage Rankings

Hakan Goker's Investments On Record (13)

Company	StageDateRound Size	Total Raised
Artios Pharma	Series DNov 2025$120M Series CJul 2021$150M Series ASep 2016$33M	$380M
Co-investors: René Kuijten (EQT Life Sciences), Florian Müllershausen (Novartis Venture Fund), Raphael Wisniewski (Andera Partners), Barbara Dalton (Pfizer Venture Investments), Nikola Trbovic (Pfizer Venture Investments), Jake Simson (RA Capital)
Actithera	Series AJul 2025$76M	$76M
Co-investors: Therese Liechtenstein (M Ventures (Merck)), Noga Yerushalmi (M Ventures (Merck))
ReproNovo	Series AMay 2025$65M	$65M
TRIMTECH Therapeutics	SeedMar 2025$31M	$31M
Co-investors: Michael Anstey (Cambridge Innovation Capital), Jeffrey Moore (MP Healthcare Venture Management), Laurence Barker (SV Health Investors)
Asceneuron	Series CJul 2024$100M Series ASep 2015$31M	$130M
Co-investors: Henrijette Richter (Soffinova Partners), Philip Scheltens (EQT Life Sciences)
iOnctura	Series BJun 2024$86M Series AJul 2020$6M Series AJan 2020$17M SeedJun 2017	$110M
Co-investors: Keno Gutierrez (BGV (BioGeneration Ventures)), Fiona MacLaughlin (Johnson & Johnson Innovation), Roel Bulthuis (INKEF Capital)
Nouscom	Series CNov 2023$73M	$140M
Co-investors: Scott Rocklage (5am Ventures), Sofia Ioannidou (Andera Partners), Guido Magni (Versant Ventures), Joachim Rothe (EQT Life Sciences), Genghis Lloyd-Harris (Abingworth)
Storm Therapeutics	Series BDec 2022$30M Series AMay 2019$18M Series AJun 2016$16M	$69M
Co-investors: Bruno Montanari (Seroba Life Sciences), Sakae Asanuma (Taiho Ventures)